St 10 - analogs
| Prices in pharmacies: Instructions St 10 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Glibenclamide ✘ (incl) Indapamide ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 48% L.i. 18 neutral
- 45% Ren 20 neutral
- 42% St 12 neutral
- 39% Ren 23 neutral
- 37% Ren 18 neutral
- 37% L.i. 17 neutral
- 37% Ren 19 neutral
- 35% Lu 3 neutral
- 33% St 11 neutral
- 31% Ren 21 neutral
- 30% Sp 20 neutral
- 30% Lu 4 neutral
- 28% Sp 18 neutral
- 26% Lu 2 neutral
- 26% St 14 neutral
- 26% Kid 23 neutral
- 25% Kid 25 neutral
- 24% Kid 24 neutral
- 24% Lu 8 neutral
- 24% Ren 22 neutral
- 23% Kid 27 neutral
- 21% Lu 6 neutral
- 20% St 16 neutral
- 19% Lu 1 neutral
- 19% Si 16 neutral
- 19% Sp 21 neutral
- 17% Gb 22 neutral
- 17% Kid 22 neutral
- 17% St 18 neutral
- 17% P 1 neutral
- 16% Ren 17 neutral
- 16% Bl 44 neutral
- 15% Tb 9 neutral
- 15% St 13 neutral
- 15% St 15 neutral
- 15% St 9 neutral
- 13% Lu 5 neutral
- 13% Gb 42 neutral
- 13% PC30 Бай-лао neutral
- 13% Du 10 neutral
- 13% Ren 16 neutral
- 12% Bl 14 neutral
- 12% L.i. 13 neutral
- 12% Bl 45 neutral
- 12% Bl 42 neutral
- 12% St 19 neutral
- 12% Du 12 neutral
- 12% Du 9 neutral
- 12% St 20 neutral
- 11% Si 15 neutral
Learn more about the selection of analogues
- The drug has «St 10» no complete analogues; 51 analog by action, the most similar - L.i. 18 .
- Medical online service has selected the best substitutes for St 10 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues St 10 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.